Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 3;189(6):90.
doi: 10.1007/s11046-024-00893-8.

Sex Differences in Allergic Bronchopulmonary Aspergillosis and its Impact on Exacerbations

Ritesh Agarwal  1 , Valliappan Muthu  2 , Inderpaul Singh Sehgal  2 , Kuruswamy Thurai Prasad  2 , Sahajal Dhooria  2 , Mandeep Garg  3 , Ashutosh N Aggarwal  2 , Shivaprakash M Rudramurthy  4 , Arunaloke Chakrabarti  5
Affiliations

Sex Differences in Allergic Bronchopulmonary Aspergillosis and its Impact on Exacerbations

Ritesh Agarwal et al. Mycopathologia. .

Abstract

The impact of sex on allergic bronchopulmonary aspergillosis (ABPA) outcomes remains uncertain. We retrospectively included ABPA subjects per the revised International Society for Human and Animal Mycology ABPA working group criteria over 13 years. We compared the clinical features, lung function, immunological tests, imaging, and ABPA exacerbation rates between men and women. Our primary objective was to assess whether women experience higher ABPA exacerbations than men. We included 731 ABPA subjects (mean age, 34.5 years; 49.5% women). Women with ABPA were older and had underlying asthma more frequently than men. There was no difference in lung function, immunological investigations, and imaging between men and women. ABPA exacerbations occurred in a slightly higher proportion of women than men (44.5% vs. 38.2%) but did not reach statistical significance (p = 0.09). We did not find a significant sex difference in ABPA exacerbation rates. Prospective studies should confirm our findings.

Keywords: Aspergillus; Allergic bronchopulmonary mycosis; Allergy; Asthma; Bronchiectasis.

PubMed Disclaimer

References

    1. Agarwal R, Sehgal IS, Muthu V, Denning DW, Chakrabarti A, Soundappan K, et al. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses. Eur Respir J. 2024;63(4):2400061. https://doi.org/10.1183/13993003.00061-2024 . - DOI - PubMed - PMC
    1. Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Aggarwal AN. Allergic bronchopulmonary aspergillosis. Clin Chest Med. 2022;43(1):99–125. https://doi.org/10.1016/j.ccm.2021.12.002 . - DOI - PubMed
    1. Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy. 2015;45(12):1765–78. https://doi.org/10.1111/cea.12595 . - DOI - PubMed
    1. Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Soundappan K, et al. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in adults with bronchial asthma: a systematic review of global data. J Allergy Clin Immunol Pract. 2023;11(6):1734–51. https://doi.org/10.1016/j.jaip.2023.04.009 . - DOI - PubMed
    1. Zein JG, Denson JL, Wechsler ME. Asthma over the adult life course: gender and hormonal influences. Clin Chest Med. 2019;40(1):149–61. https://doi.org/10.1016/j.ccm.2018.10.009 . - DOI - PubMed

LinkOut - more resources